Skip to main content
Smart Investors Daily
CL

NASDAQ · CLGN

CollPlant Biotechnologies Ltd.

Healthcare · Biotechnology

$4.64

Up+$0.68 (+17.17%)

Updated Nov 17, 2026, 7:06 AM

SID Score

5.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
23.78M
P/E ratio
-1.96
Dividend yield
0.00%
52-week range
$0.26 – $9.60
Volume
439.3K
Avg. volume
99.32K

Price performance · CLGN

CLGN price history

1M range · 19 trading sessions · Daily adjusted prices

Prices through Nov 12, 2026

CLGN closed at $4.64 after 19 trading sessions, up 30.34% for the selected period.

Last close
$4.64
Period change
+30.34%
Period low
$3.56
Period high
$4.64
Daily close
View OHLC price history
CLGN OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 12, 2026$4.05$4.64$4.05$4.64439.3K
Nov 11, 2026$4.0254$4.1999$3.86$3.9625.05K
Nov 10, 2026$4.15$4.15$3.86$3.90522.14K
Nov 9, 2026$4.00$4.29$3.7622$4.2923.99K
Nov 6, 2026$4.18$4.1895$3.85$3.9729.22K
Nov 5, 2026$4.13$4.25$3.94$3.94100.47K
Nov 4, 2026$4.19$4.50$4.08$4.2336.18K
Nov 3, 2026$4.01$4.4399$3.99$4.1122.97K
Nov 2, 2026$4.15$4.20$3.95$4.0840.5K
Oct 30, 2026$4.20$4.60$4.10$4.13544.25K
Oct 29, 2026$4.10$4.70$3.8701$4.40167.1K
Oct 28, 2026$3.87$4.00$3.75$3.959.25K
Oct 27, 2026$3.78$3.96$3.63$3.9038.04K
Oct 26, 2026$3.67$3.91$3.65$3.7533.81K
Oct 23, 2026$3.60$3.72$3.52$3.6712.1K
Oct 22, 2026$3.71$3.74$3.41$3.6210.6K
Oct 21, 2026$3.80$3.81$3.551$3.7559.68K
Oct 20, 2026$3.5703$3.88$3.5302$3.8820.36K
Oct 19, 2026$3.62$3.68$3.45$3.5628.97K

Latest CLGN news

The latest Smart Investors Daily articles mentioning CLGN.

CLGN research

Overview

Company profile and research snapshot.

Company profile

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$12.50
Implied upside
—
Analysts
—
CLGN recent ratings
DateFirmRatingTarget
Feb 6, 2026D. Boral CapitalHold—
Nov 28, 2025D. Boral CapitalBuy—
Oct 20, 2025D. Boral CapitalBuy—
Sep 16, 2025D. Boral CapitalBuy—
Aug 21, 2025HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 12, 2026

CollPlant to Begin Trading on Nasdaq Under New Ticker Symbol “OPHI”

OPHI marks another important step in CollPlant’s strategy to expand and focus its operations built around LightSolver’s all-optical Laser Processing Unit (LPU)™Rehovot, Israel, Nov. 12, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) (“CollPlant”) today announced that its ordinary shares will begin trading on Nasdaq under the new ticker symbol “OPHI,” effective at the open of trading on November 13, 2026. The shares will continue to trade under “CLGN” through the close of

Yahoo · Nov 11, 2026

LightSolver to Unveil the First Public Demonstration of its All-Optical Computer at SC26

LightSolver to present its Boeing corrosion-simulation work and join Birds of a Feather (BoF) session on analog computing at the supercomputing conference in ChicagoRehovot, Israel, Nov. 11, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd. (“LightSolver”), a pioneer of pure photonic computing and developer of the Laser Processing Unit (LPU)™, will unveil the LPU capabilities in a first public demonstration at SC26, the In

Yahoo · Nov 5, 2026

LightSolver Secures ~$1.8 Million Grant from Israel’s Innovation Authority to Advance its Laser Processing Unit (LPU)

Government-backed R&D program to advance next-generation LPU hardware and expand the LPU Lab platform Builds on LightSolver’s recent commercial and technical momentum, including the strategic partnership with Boeing, peer-reviewed research with HLRS and a growing IP portfolio Rehovot, Israel, Nov. 05, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that the Israel Innovation Authority (IIA) has approved a grant of approximately $1.8 million to its subsidiar

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.